SCHEMBL25848288

SCHEMBL25848288

C=CC(=O)OC1CCC(Oc2ccc3cc(-c4ccc(CCCCC)cc4OC(F)(F)F)c(=O)oc3c2)C1(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.37
STS P08842 1/20 0.33
MAOA P21397 2/20 0.32
MAOB P27338 2/20 0.32
KDM4E B2RXH2 4/20 0.32
HPGD P15428 4/20 0.32
ALDH1A1 P00352 3/20 0.32
GLA P06280 2/20 0.32
GAA P10253 2/20 0.32
LMNA P02545 1/20 0.32
NOD2 Q9HC29 1/20 0.32
NPC1 O15118 3/20 0.31
RAB9A P51151 3/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
ACHE P22303 1/20 0.31
BACE1 P56817 1/20 0.31
PTPN7 P35236 1/20 0.30
S1PR1 P21453 1/20 0.30
S1PR3 Q99500 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625106 0.93 THRB (0.36) THRBSTSMAOAMAOBKDM4E
SCHEMBL25848291 0.92 THRB (0.39) THRBMAOAMAOBKDM4EHPGD
SCHEMBL25848290 0.90 STS (0.33) STSMAOAMAOBKDM4EHPGD
SCHEMBL25848279 0.89 THRB (0.41) THRBSTSMAOAMAOBKDM4E
SCHEMBL25848282 0.89 THRB (0.40) THRBMAOAMAOBKDM4EHPGD
SCHEMBL22624982 0.88 THRB (0.37) THRBMAOAMAOBKDM4EHPGD
SCHEMBL25848299 0.87 RAB9A (0.38) MAOAMAOBKDM4EHPGDALDH1A1
SCHEMBL22625061 0.87 THRB (0.37) THRBSTSMAOAMAOBKDM4E
SCHEMBL25848265 0.87 THRB (0.37) THRBSTSMAOAMAOBKDM4E
SCHEMBL21735060 0.85 THRB (0.37) THRBS1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 THRB 3289/4885STS 4081/4885MAOA 2922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.